A reduction in GABAergic neurotransmission has been put forward as a pathophysiological mechanism for human epilepsy. However, in slices of human epileptogenic neocortex, GABAergic inhibition can be clearly demonstrated. In this article we present data showing an increase in the functional lability of GABAergic inhibition in epileptogenic tissue compared with nonepileptogenic human tissue. We have previously shown that the glycolytic enzyme GAPDH is the kinase involved in the glycolysis-dependent endogenous phosphorylation of the ␣1-subunit of GABAA receptor, a mechanism necessary for maintaining GABA A function. In human epileptogenic cortex obtained during curative surgery of patients with partial seizures, we demonstrate an intrinsic deficiency of GABA A receptor endogenous phosphorylation resulting in an increased lability of GABAergic currents in neurons isolated from this tissue when compared with neurons from nonepileptogenic human tissue. This feature was not related to a reduction in the number of GABA A receptor ␣1-subunits in the epileptogenic tissue as measured by [ 3 H]flunitrazepam photoaffinity labeling. Maintaining the receptor in a phosphorylated state either by favoring the endogenous phosphorylation or by inhibiting a membrane-associated phosphatase is needed to sustain GABA A receptor responses in epileptogenic cortex. The increased functional lability induced by the deficiency in phosphorylation can account for transient GABAergic disinhibition favoring seizure initiation and propagation. These findings imply new therapeutic approaches and suggest a functional link to the regional cerebral glucose hypometabolism observed in patients with partial epilepsy, because the dysfunctional GABAergic mechanism depends on the locally produced glycolytic ATP.GABAA receptor phosphorylation ͉ GAPDH ͉ human epilepsy ͉ neuronal inhibition P rotein phosphorylation is an important mechanism for the rapid modulation of ion channel properties. Receptorassociated endogenous phosphorylation is required for maintaining the GABA A currents, the principal inhibitory system in the mammalian brain (1, 2). We have identified the kinase of the endogenous phosphorylation as being GAPDH (3), a key glycolytic enzyme. GAPDH is closely associated with the GABA A receptor (GABA A R) macrocomplex at the plasma membrane. GAPDH has a dual role, first as a dehydrogenase in the glycolysis cascade contributing to ATP production and second as a kinase phosphorylating the GABA A R ␣1-subunit (3). All factors promoting the GAPDH-dependent ␣1-phosphorylation also favor the maintenance of the receptor in a functional state, thus directly linking GABAergic inhibition with glucose metabolism. The ␣1-phosphorylation state of the receptor also depends on a membrane-bound phosphatase that is yet to be characterized (4).A wealth of studies have shown that a decrease, even transient, in the efficacy of the GABA A inhibition induces pathological neuronal synchronization resulting in epileptic seizures (5, 6). A deficiency of endogenous GABA A R...